Patrick J. McEnany - 11 Nov 2024 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director, Chairman of Board of Directors
Signature
/s/ Patrick J. McEnany
Issuer symbol
CPRX
Transactions as of
11 Nov 2024
Net transactions value
-$9,627,422
Form type
4
Filing time
13 Nov 2024, 17:44:37 UTC
Previous filing
26 Aug 2024
Next filing
15 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $922,300 +230,000 +5.1% $4.01 4,708,169 11 Nov 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $5,416,040 -230,000 -4.9% $23.55 4,478,169 11 Nov 2024 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $280,700 +70,000 +1.6% $4.01 4,548,169 12 Nov 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $1,639,470 -70,000 -1.5% $23.42 4,478,169 12 Nov 2024 Direct F1, F3
transaction CPRX Common stock, par value $0.001 per share Options Exercise $679,680 +192,000 +4.3% $3.54 4,670,169 12 Nov 2024 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $4,454,592 -192,000 -4.1% $23.20 4,478,169 12 Nov 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -230,000 -8.9% $0.000000 2,362,745 11 Nov 2024 Common Stock 230,000 $4.01 Direct F5
transaction CPRX Options to purchase common stock Options Exercise $0 -70,000 -3% $0.000000 2,292,745 12 Nov 2024 Common Stock 70,000 $4.01 Direct F5
transaction CPRX Options to purchase common stock Options Exercise $0 -192,000 -8.4% $0.000000 2,100,745 12 Nov 2024 Common Stock 192,000 $3.54 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold for personal reasons, including paying federal income taxes and diversifying the Reporting Person's portfolio. Shares were not sold as a result of any disagreement with the Company. Mr. McEnany remains the non-executive chairman of the Company's Board of Directors and the Company's largest individual, non-institutional shareholder.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.29 to $23.873 per share.
F3 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.30 to $23.50 per share.
F4 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $23.03 to $23.48 per share.
F5 Options vested in three equal tranches on January 2, 2019, 2020 and 2021.
F6 Options vested in three equal tranches on May 29, 2019, 2020 and 2021.